TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
SBM Life Science AB
Closing information (x1000 SEK)
| Closing information | 2023/09 | 2022/09 | 2021/09 |
| Turnover |
179,947
|
214,273
|
202,987 |
| Financial expenses |
6,067
|
5,307
|
2,923 |
| Earnings before taxes |
-1,360
|
4,214
|
5,212 |
| EBITDA |
3,837
|
8,986
|
7,747 |
| Total assets |
104,790
|
166,764
|
86,212 |
| Current assets |
103,714
|
165,796
|
84,243 |
| Current liabilities |
88,164
|
148,884
|
71,657 |
| Equity capital |
16,626
|
17,880
|
14,555 |
| - share capital |
50
|
50
|
50 |
| Employees (average) |
18
|
19
|
27 |
Financial ratios
| Fiscal year | 2023/09 | 2022/09 | 2021/09 |
| Solvency |
15.9%
|
10.7%
|
16.9% |
| Turnover per employee |
9,997
|
11,278
|
7,518 |
| Profit as a percentage of turnover |
-0.8%
|
2.0%
|
2.6% |
| Return on assets (ROA) |
4.5%
|
5.7%
|
9.4% |
| Current ratio |
117.6%
|
111.4%
|
117.6% |
| Return on equity (ROE) |
-8.2%
|
23.6%
|
35.8% |
| Change turnover |
-34,326
|
11,286
|
9,101 |
| Change turnover % |
-16%
|
6%
|
5% |
| Chg. No. of employees |
-1
|
-8
|
-3 |
| Chg. No. of employees % |
-5%
|
-30%
|
-10% |
Total value of public sale
| Fiscal year | 2023/09 | 2022/09 | 2021/09 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.